The University of Ottawa Heart Institute is pleased to announce Benjamin Hibbert, MD, PhD, was named the 2021 UOHI Investigator of the Year – Clinical Science. This award recognizes Dr. Hibbert’s outstanding research achievements in the past year.
Dr. Hibbert is appointed as an Interventional Cardiologist at the UOHI and an Assistant Professor in the Department of Medicine at the University of Ottawa. Dr. Hibbert’s innovative program is focused on outcomes research and translational science.
Dr. Hibbert currently is leading numerous clinical trials. He has authored 166 peer-reviewed articles at this early career stage. Importantly, in 2021 Dr. Hibbert published a total of 28 papers and a number of impactful, practice-changing studies. These include studies on the methodological rigor in preclinical cardiovascular research – this work has already led to practice changes at Circulation Research. Other impactful publications include studies on outcomes of transcatheter mitral valve repair in patients with cardiogenic shock, and impact of sex as a biological variable after mitral valve repair.
Most significantly, Dr. Hibbert conducted the “DOREMI” trial, comparing the safety and efficacy of two inotropic medicines used to treat cardiogenic shock. The study showed, either Dobutamine or Milrinone, resulted in comparable patient outcomes. This work settled the debate whether Milrinone was superior to Dobutamine; the selection of which medicine to use now can be based on physician comfort, cost, and response to therapy. It was published in the prestigious New England Journal of Medicine, and recently earned Dr. Hibbert a Publication of The Year Award – Clinical at the University of Ottawa’s Faculty of Medicine.
Dr. Hibbert has been mentoring several junior investigators, many of whom are now faculty at the Heart Institute or U.S. institutions.
Congratulations to Dr. Hibbert on these remarkable achievements!